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Glycosylphosphatidylinositol (GPI) anchoring of proteins is a conserved post-translational modiﬁca-
tion in eukaryotes. In mammalian cells, approximately 150 proteins on the plasma membrane are
attached to the cell surface by GPI anchors, which confer speciﬁc properties on proteins, such as
association with membrane microdomains. The structures of lipid and glycan moieties on GPI
anchors are remodeled during biosynthesis and after attachment to proteins. The remodeling pro-
cesses are critical for transport and microdomain-association of GPI-anchored proteins. Here, we
describe the structural remodeling of GPI anchors and genes required for the processes in mammals,
yeast, and trypanosomes.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Structure of GPI anchors in mammals, yeast, and
trypanosomes
Glycosylphosphatidylinositol (GPI) anchors have a common
core structure, EtNP-6Mana1-2Mana1-6Mana1-4GlcNa1-6myo-
Inositol-phospholipid (Fig. 1A), which is conserved among all
species (EtNP, ethanolamine-phosphate; Man, mannose; GlcN,
glucosamine) [1–3]. There is variability in the side-chains and lipid
moieties of GPI anchors dependent upon proteins and species.
Additionally, there are differences between the structures of phos-
phatidylinositol (PI), which is the starting material for GPI, the GPI
complete precursor just before attachment to a protein, and
matured GPI-anchored proteins (GPI-APs) on the cell surface
(Fig. 1B). This would suggest that GPI structures are remodeled
during biosynthesis and after attachment to proteins.
1.1. Structure of GPI anchors in mammals
The biosynthesis of GPI is essential for embryogenesis, but not
for cellular level in mammals [4]. GPI is synthesized from conven-
tional diacyl-PI, such as 1-stearoyl(C18:0)-2-arachidonoyl(C20:4)-chemical Societies. Published by E
for Microbial Diseases, Osaka
233.
inoshita).PI. The majority of the lipid portion of the GPI complete precursor,
however, is 1-alkyl-2-acyl-glycerol. GPI precursors labeled with
[3H] Man are designated H2 to H8 in order of polarity [5]. The com-
plete precursor, H8, consists of EtNP-Man-(EtNP)Man-(EtNP)Man-
GlcN-(acyl)PI. Occasionally, the fourth Man residue (Man4) is
linked via an a1-2 bond to the third Man residue (Man3). Most
GPI-APs have a saturated acyl-chain (stearic acid) at the sn-2 posi-
tion in the lipid moiety [2], whereas free PI and complete precursor
have an unsaturated fatty acid at the sn-2 position. All mammalian
GPI-APs have a side-chain EtNP on the ﬁrst Man (Man1) (R2 in
Fig. 1). GPI-APs on human erythrocytes have an exceptional lipid
structure [6]. They contain an unsaturated fatty acid in the sn-2 po-
sition, and the acyl-chain, which is usually removed soon after GPI
attachment to proteins, is retained on the 2-position of inositol. In
mature GPI-APs, there are heterogeneities in the glycan side-chains
[7]. b-N-Acetylgalactosamine (GalNAc) could be linked to the Man1
residue at the 4-position. GalNAc is occasionally modiﬁed by gal-
actose with or without sialic acid [8]. The majority of GPI-APs lack
an EtNP side-chain on the second Man (Man2), which is added dur-
ing biosynthesis [1,7].
1.2. Structure of GPI anchor in budding yeast
In the budding yeast Saccharomyces cerevisiae, the biosynthesis
of GPI is essential for growth [9], and its synthesis starts fromlsevier B.V. All rights reserved.
Fig. 1. Structures of PI, GPI complete precursor and GPI-AP in mammals, yeast and trypanosomes. (A) Core structure of the GPI anchor. R1–R6, side-chains; Ino, inositol; GlcN,
glucosamine; Man, mannose; EtNP, ethanolamine-phosphate; Pho, phosphate. (B) Various side-chain modiﬁcations and lipid moiety of GPI anchors in mammals, yeast, and
bloodstream and procyclic forms of trypanosomes are indicated. Lipid and R1–R6 correspond to those in (A). PI, phosphatidylinositol; CP, GPI complete precursor.
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position, such as 1-palmitoyl(C16:0)-2-oleoyl(C18:1)-PI. The struc-
ture of the complete precursor is Man-(EtNP)Man-(EtNP)Man-
(EtNP)Man-GlcN-(acyl)PI. Man4 is essentially linked to the com-
plete precursor. The lipid moiety of the complete precursor ap-
pears to be the same as the starting PI containing diacylglycerol
with an unsaturated fatty acid. In contrast, the lipid portion of ma-
ture GPI-APs is either diacylglycerol containing C26:0, a very long
chain fatty acid at the sn-2 position or ceramide [10,11]. Ceramide
can be classiﬁed into two types: ceramide consisting of phyto-
sphingosine (PHS) with C26:0 fatty acid, or PHS with monohydr-
oxylated C26:0. The glycan moiety of yeast GPI-APs contains
more Man linked to Man4 via a1-2 or a1-3 bonds, with these mod-
iﬁcations occurring in the Golgi [9]. It is unclear whether mature
GPI-APs retain side-chain EtNPs on Man1 and Man2, whereas GPI
precursors have these side-chains [10].
1.3. Structure of GPI anchor in African trypanosome
The African trypanosome, Trypanosoma brucei, has two prolifer-
ative stages, the bloodstream form that grows in the blood plasma
of mammalian hosts and the procyclic form that grows in the mid-
gut of tsetse ﬂy vector. The cell surface of the bloodstream form of
the parasite is coated by a single GPI-AP, variant surface glycopro-
tein (VSG). GPI biosynthesis is essential for growth of the blood-
stream form [12] as well as being recognized as a target for anti-
trypanosomal drug development [13,14]. The complete precursor
and GPI-APs do not have an EtNP side-branch in T. brucei. The gly-
can component of the GPI anchor on the VSG has side-branches
consisting of only galactoses and has strictly di-myristoyl-PI. The
di-myristoyl-PI moiety is generated by fatty acid remodeling
occurring before attachment to proteins [13].
The surface of the procyclic form of the parasite is coated by
procyclins, GPI-APs with a large side-branch of GPI containing ter-
minal sialic acids. GPI biosynthesis is not essential for growth ofthe procyclic form in vitro, but it is critical for survival in the tsetse
ﬂy [15]. The lipid portion of procyclin is unusual in that it has lyso-
PI with a palmitoyl-chain linked to the inositol ring [16]. The gly-
can part of procyclin has a large Man1-linked side-chain consisting
of repeated and branched lactosamines [16]. Sialic acids are linked
to some of the galactoses in the side-chain.
2. GPI biosynthesis and attachment to proteins in mammalian
cells
2.1. Biosynthesis of GPI
GPI is synthesized by the sequential addition of sugars, an acyl-
chain, and EtNPs to PI in the endoplasmic reticulum (ER) [2,3]. At
least eleven reaction steps are required for the generation of the
GPI complete precursor, H8, before it is ready for attachment to
proteins (Fig. 2 and Table 1). The biosynthetic pathway is initiated
on the cytoplasmic side of the ER membrane by the transfer of N-
acetylglucosamine (GlcNAc) to PI from UDP-GlcNAc, generating
GlcNAc-PI (Step 1). GPI-GlcNAc transferase (GPI-GnT), a multi-sub-
unit enzyme consisting of seven components (PIG-A, PIG-C, PIG-H,
PIG-P, PIG-Q, PIG-Y, and DPM2), catalyzes this reaction. The PIG-A
gene encoding the catalytic subunit of GPI-GnT is located on the X
chromosome and the somatic mutation is a key event leading to
paroxysmal nocturnal hemoglobinuria, an acquired hematopoietic
stem-cell disorder [17]. GlcNAc-PI is next de-N-acetylated to gen-
erate GlcN-PI (Step 2), which is mediated on the cytoplasmic side
of the ER by PIG-L. It is most likely that GlcN-PI is ﬂipped into
the luminal side of the ER (Step 3), where all later reactions occur.
An acyl-chain, usually palmitic acid, is then added to the 2-position
of the inositol ring from acyl-CoA to form GlcN-(acyl)PI (Step 4).
This reaction is mediated by acyltransferase PIG-W, with the mem-
brane orientation of its catalytic site yet to be determined. A puta-
tive protein required for ﬂipping of GlcN-PI has not been identiﬁed,
whereas yeast Arv1p might be involved in ﬂipping of the GPI inter-
Fig. 2. Biosynthesis and remodeling of mammalian GPI-APs. Steps 1–11, TA, ID, GR, FR1, and FR2 correspond to those shown in Table 1. TA, transamidation; ID, inositol
deacylation; GR, glycan remodeling; FR, fatty acid remodeling; Dol-P-Man, dolichol-phosphate-mannose; PE, phosphatidylethanolamine.
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I (GPI-MT I). Diacyl-PI moieties of GlcN-(acyl)PI are exchanged to
diradyl-PIs, mixture of alkylacyl-PIs and diacyl-PIs (Step 5), as
described in Section 4. Then, Man1 and Man2 are sequentially
transferred to GlcN-(acyl)PI from dolichol-phosphate-mannose
(Dol-P-Man) to generate Man-Man-GlcN-(acyl)PI (Steps 6 and 7).
Man1-linked to GlcN via an a1-4 linkage is transferred by the
GPI-MT I complex (PIG-M, a catalytic subunit; PIG-X, a regulatory
subunit). It has been reported that defective expression of PIG-M
due to a point mutation in the promoter region causes an inherited
GPI deﬁciency that leads to thromboses of the portal and hepatic
veins as well as seizures [18,19]. Man2 linked to Man1 via an
a1-6 linkage is transferred by GPI-MT II (PIG-V). An EtNP is trans-
ferred to the 2-position of Man1 from phosphatidylethanolamine
(PE) generating Man-(EtNP)Man-GlcN-(acyl)PI (Step 8). This reac-
tion is mediated by PIG-N, GPI-EtNP transferase I (GPI-ET I).
Man3 is then transferred from Dol-P-Man by PIG-B, GPI-MT III
(Step 9), generating Man-Man-(EtNP)Man-GlcN-(acyl)PI. Man4
could be transferred from Dol-P-Man by PIG-Z/SMP3, GPI-MT IV
(Step M4). Man4 is essential in yeast, whereas it is a common
but minor component in mammalian cells, and its biological
requirement is yet to be clariﬁed. The so-called ‘bridging’ EtNP that
makes an amide bond with the protein’s C-terminus is added to the
6-position of Man3 from PE (Step 10) generating EtNP-Man-Man-
(EtNP)Man-(acyl)PI. This reaction is mediated by the GPI-ET III
complex (PIG-O, a catalytic subunit, and PIG-F, a regulatory sub-
unit). A side-chain EtNP is transferred to the 6-position of Man2
from PE (Step 11), generating EtNP-Man-(EtNP)Man-(EtNP)Man-GlcN-(acyl)PI. This step is mediated by the GPI-ET II complex
(PIG-G/GPI7, a catalytic subunit and PIG-F, a regulatory subunit).
2.2. Attachment of GPI to proteins
The GPI complete precursor is then transferred to proteins by
GPI transamidase (Step TA), which is a membrane-bound multi-
subunit enzyme (PIG-K/GPI8, GAA1, PIG-S, PIG-T, and PIG-U)
[2,3]. PIG-K is the catalytic subunit that has homology to the cys-
teine protease family members. GPI transamidase recognizes pro-
teins bearing the GPI attachment signal at the carboxyl terminus,
and cleaves off the signal peptide, forming an enzyme–substrate
intermediate linked via thioester. Nucleophilic attack by the termi-
nal amino group in GPI breaks the thioester, generating GPI-AP.
3. Structural remodeling after attachment of GPI to proteins in
mammalian cells and yeast
3.1. Inositol deacylation by PGAP1
In Step 4 in the GPI biosynthetic pathway, an acyl-chain is
added to the 2-position of the inositol ring of the GPI intermediate
GlcN-PI by mammalian PIG-W or its yeast homolog Gwt1p, gener-
ating GlcN-(acyl)PI (Fig. 2) [20,21]. This reaction is required for
the efﬁcient biosynthesis and attachment of GPI, because the
amount of GPI-APs are dramatically decreased in PIG-W-deﬁcient
cells or gwt1 mutant cells. Soon after attachment of GPI to pro-
teins the acyl-chain is eliminated from the inositol of the GPI an-
Table 1
Genes required for biosynthesis and remodeling of GPI anchor.
Step Donor substrate Mammals S. cerevisiae T. brucei
1 GPI-GlcNAc transferase (GPI-GnT) UDP-GlcNAc PIG-A GPI3 TbGPI3
PIG-C GPI2 TbGPI2
PIG-H GPI15 TbGPI15?
PIG-P GPI19 TbGPI19
PIG-Q GPI1 TbGPI1
PIG-Y ERI1 –
DPM2 – –
2 GlcNAc-PI de-N-acetylase PIG-L GPI12 TbGPI12
3 Flippase Not identiﬁed ARV1? Not identiﬁed
4 Inositol acyltransferase Palmitoyl-CoA PIG-W GWT1 –
Not identiﬁeda
5 PI remodeling enzyme ? Not identiﬁed – –
6 a1-4mannosyltransferase I (GPI-MT I) Dol-P-Man PIG-M GPI14 TbGPI14
PIG-X PBN1 –
7 a1-6mannosyltransferase II (GPI-MT II) Dol-P-Man PIG-V GPI18 TbGPI18
– PGA1 –
8 EtNP transferase I (GPI-ET I) PE PIG-N MCD4 –
9 a1-2mannosyltransferase III (GPI-MT III) Dol-P-Man PIG-B GPI10 TbGPI10
M4 a1-2mannosyltransferase IV (GPI-MT IV) Dol-P-Man PIG-Z (SMP3) SMP3 –
10 EtNP transferase III (GPI-ET III) PE PIG-O GPI13 TbGPI13
PIG-F GPI11 TbGPI11?
11 EtNP transferase II (GPI-ET II) PE PIG-G (GPI7) GPI7 –
PIG-F GPI11
TA GPI transamidase PIG-K GPI8 TbGPI8
GAA1 GAA1 TbGAA1
PIG-S GPI17 –
PIG-T GPI16 TbGPI16
PIG-U GAB1 –
– – TTA1b
– – TTA2
ID Inositol deacylase PGAP1 BST1 GPIdeAc2
(GPIdeAc)
GR 2nd EtNP phosphoesterase PGAP5 CDC1
TED1
–
FR1 GPI-phospholipase A2 PGAP3 PER1 –
Not identiﬁeda
FR2 Lyso-GPI acyltransferase I Stearyl-CoA PGAP2 CWH43-N? –
Not identiﬁed GUP1 TbGUP1
CR Ceramide remodelase Ceramide? CWH43 –
FR3 GPI phospholipase A1 – – Not identiﬁed
FR4 Lyso-GPI acyltransferase II – – Not identiﬁed
a The reactions exist, but the homologs required for the reactions are not found.
b TTA1 is remotely related to PIG-S.
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by mammalian PGAP1 (post-GPI attachment to protein 1) or the
yeast ortholog Bst1p, a deacylase bearing the lipase motif (GxSxG)
with a catalytic serine [22,23]. The inositol deacylation occurs in
most cell types except human erythrocytes. After inositol deacyl-
ation, GPI-APs become sensitive to cleavage by PI-speciﬁc phos-
pholipase C (PI-PLC). Deacylation from inositol by PGAP1/Bst1p
occurs before GPI-APs exit the ER, and is critical for the efﬁcient
transport of GPI-APs from the ER to the Golgi. Interestingly, yeast
BST1 was originally isolated as a gene that synthetically rescues
the lethality of sec13 (encoding a component of COPII) mutant
cells [24]. EMP24 and ERV25, which are members of the p24 fam-
ily in yeast and facilitate efﬁcient cargo packaging of GPI-APs from
the ER [25], were also isolated. In mammalian cells, efﬁcient
transport of GPI-APs also requires the p24 family members [26].
Furthermore, the inositol deacylation process is required for the
efﬁcient degradation of misfolded GPI-anchored proteins via ER-
associated degradation [22], and is essential for fatty acid remod-
eling [27,28].It has been reported that the majority of the PGAP1-knockout
mice die quickly after birth, often with the phenotype of otoceph-
aly due to malformation of the jaw, indicating the importance of
GPI lipid structure in GPI-AP function during development [29].
That phenotype is consistent with a recent report that PGAP1 is
the gene being responsible for oto mutation in mice, which causes
defects in Wnt signaling and forebrain truncation [30]. It is still un-
clear how the mutation in PGAP1 affects Wnt signaling, but it has
been reported that PGAP1 is involved in Wnt maturation, probably
by the addition of GPI-like anchors to Wnt1 and Wnt3a [30]. In
PGAP1-knockout mice, survivors grew with signiﬁcantly reduced
body weight, and male infertility was observed due to the inability
of sperm to ascend from the uterus to the oviduct and attach to the
zona pellucida of the egg [29]. The levels of sperm-associated GPI-
APs, such as CD52 and DAF/CD55 were increased in sperm from the
PGAP1-knockout mice. Much of the sperm-associated GPI-APs are
synthesized in the epididymis epithelial cells and are transferred
to sperm possibly via vesicles called epididymosomes. One of the
receptors for decapacitation factors that inhibit sperm maturation
1674 M. Fujita, T. Kinoshita / FEBS Letters 584 (2010) 1670–1677is a sperm-associated GPI-AP [31]. Inositol-acylated GPI-APs might
be more stably associated with the sperm surface and hence more
decapacitation factors would be associated, inhibiting sperm
maturation.
3.2. Glycan remodeling of GPI anchor: removal of the second EtNP by
PGAP5
GPI bears a complex glycan portion between a protein and its
lipid anchor, but the function of the glycan moiety is not well
understood. There is a structural difference between the glycan
moieties of GPI just before attachment to proteins in the ER and
GPI-APs on the cell surface. In the GPI biosynthetic pathway, a
side-chain EtNP can be attached to the Man2 of the GPI intermedi-
ate by PIG-G/GPI7 and PIG-F, thereby generating the complete pre-
cursor H8 [5,32]. However, most GPI-APs on the cell surface do not
contain the side-chain EtNP on Man2 [1]. Therefore, it has been
considered that the GPI structure, H7, which lacks a side-chain
EtNP on Man2, may be the major precursor for protein attachment,
and that H8 is a structural variant of H7 with a similar function. In
yeast, it also has been reported that GPI precursor contains side-
chain EtNPs, but the protein-bound GPI anchors do not bear those
side-chain EtNPs [10,33].
Recently, it has been found that Chinese hamster ovary (CHO)
cells isolated from screening for cells defective in transporting
GPI-APs are defective in a gene named PGAP5 [34]. PGAP5 is an en-
zyme that belongs to a dimetal-containing phosphoesterase family
and catalyzes the removal of a side-chain EtNP attached to the
Man2 of GPI (GR in Fig. 2). In PGAP5 mutant cells, transport of
GPI-APs from the ER is signiﬁcantly delayed, indicating that GPI-
glycan remodeling mediated by PGAP5 regulates exit of GPI-APs
from the ER.
Two PGAP5 homologs, CDC1 and TED1, exist in the yeast gen-
ome. Both of them have genetic interactions with GPI-related
genes. TED1 is thought to act together with EMP24 and ERV25 in
the ER exit [35]. Transport of Gas1p, a GP-AP, from the ER is de-
layed in ted1 mutant cells. The other yeast homolog, CDC1, was
originally identiﬁed in a screen for cell division cycle defects
[36]. Temperature sensitivity of cdc1 mutant cells was rescued by
addition of Mn2+ [37], consistent with the requirement of Mn2+
for PGAP5 enzymatic activity. Furthermore, mutation in CDC1 is
suppressed by additional mutations in COS16/PER1 and GUP1
[37,38], both of which are involved in lipid remodeling of GPI-
APs as described below. It is not clear why two PGAP5 homologs
exist in yeast. In yeast, two types of lipid remodeling of GPI-APs
take place in the ER, resulting in GPI-APs containing either cera-
mide-based lipid or diacylglycerol-based lipid containing a very
long fatty acid at the sn-2 position [11]. One possibility is that
two PGAP5 homologs are required for the recognition and cleavage
of the side-chain EtNP from yeast GPI-APs containing different li-
pid moieties. Alternatively, since side-chain EtNPs on Man1 and
Man2 are missing in the mature GPI-APs in yeast [10], the other
possibility is that Cdc1p and Ted1p cleave each side-chain EtNPs
on Man1 and Man2, respectively.
3.3. Fatty acid remodeling of GPI anchors is essential for raft-
association of GPI-APs
One of the most characteristic features of GPI-APs is their asso-
ciation with membrane microdomains or membrane rafts [39].
Membrane rafts are dynamic membrane domains (10–200 nm) en-
riched in sphingolipids and cholesterol. Isolation of detergent
resistant membranes (DRMs) is only a way of the biochemical
analysis for the raft-association, although they might not represent
the physiological status of membrane rafts. GPI-APs are efﬁciently
recovered into the DRM fraction when cells are extracted with coldnon-ionic detergent, such as Triton X-100. The lipid structure of
GPI anchors are critical for the integration of GPI-APs into the
membrane rafts [40]. GPI-APs usually have two saturated fatty
chains in the lipid moiety, which have been thought to make asso-
ciations with the ceramide moiety of sphingolipids and with cho-
lesterol, the basis of raft-association of GPI-APs. The lipid moiety
of GPI-APs bearing two saturated chains is generated by fatty acid
remodeling, and this remodeling is mediated by mammalian
PGAP3/yeast Per1p, mammalian PGAP2 and yeast Gup1p as de-
scribed below.
3.3.1. Removal of unsaturated fatty acid from the sn-2 position in GPI
anchor
The ﬁrst step in fatty acid remodeling is removal of the unsatu-
rated acyl-chain from the sn-2 position to form lyso-GPI (FR1 in
Fig. 2). Mammalian PGAP3 and yeast Per1p are required for the for-
mation of lyso-GPI [28,41]. It is not yet known whether PGAP3/
Per1p is the enzyme itself for GPI-phospholipase A2 or the regula-
tor, whereas two histidine residues (H177 and H326 in Per1p) in
the regions conserved among Per1p homologs are essential for
their function. Lipid moieties of GPI-APs in wild-type yeast bear
a diacylglycerol containing a C26:0 very long chain fatty acid at
the sn-2 position or a C26-containing-ceramide, whereas those in
per1 mutant cells contain a diacylglycerol with usual fatty acids.
Mammalian PGAP2 & 3 double mutant cells also possess an unsat-
urated fatty acid at the sn-2 position in GPI anchors, whereas the
unsaturated chain is replaced by the saturated stearoyl chain in
wild-type cells. In both yeast per1 mutant cells and mammalian
PGAP2 & 3 double mutant cells, GPI-APs were not associated with
the DRMs. Thus, fatty acid remodeling by PGAP3/Per1p is essential
for association of GPI-APs with lipid microdomains.
Fatty acid remodeling of GPI-APs takes place at different sites in
yeast and mammalian cells; in yeast this reaction takes place in the
ER, whereas in mammals this remodeling occurs in the Golgi
[28,41]. Per1p is mainly localized in the ER and PGAP3 is localized
mainly in the Golgi and weakly in the ER. This is consistent with
the place where GPI-APs are incorporated into membrane rafts in
these organisms. In yeast, GPI-APs are associated with ceramide-
enriched membranes in the ER, whereas mammalian GPI-APs tend
to be incorporated into rafts in the Golgi.
3.3.2. Transfer of saturated fatty acid to lyso-GPI anchor
The second step in fatty acid remodeling is the transfer of a
saturated acyl-chain to lyso-GPI (FR2 in Fig. 2). The saturated
acyl-chain is usually C26:0 in yeast and C18:0, stearic acid, in
mammalian cells. The difference in the length of remodeled fatty
acid between yeast and mammalian cells seems to correlate with
the typical chain length of sphingolipids, which contain a C26 fatty
acid in yeast and C16–24 fatty acids, but mainly C18 fatty acid in
mammalian cells.
Mammalian PGAP2 is involved in reacylation, speciﬁcally in
transferring the C18:0 chain to the lyso-GPI [42]. The precise func-
tion of PGAP2 is still unknown, although it is probably not an acyl-
transferase because it has no homology to acyltransferases. PGAP2
is a membrane-bound protein expressed mainly in the Golgi and
weakly in the ER. The GPI lipid moiety in PGAP2-deﬁcient mutant
CHO cells is mainly lyso-GPI. The lyso-GPI-APs seem to be sensitive
to an unknown phospholipase D and secreted out of the cells.
PGAP2, also known as FRAG1, has been reported to make a fusion
protein with ﬁbroblast growth factor receptor 2, having a constitu-
tively elevated tyrosine kinase activity in a rat osteosarcoma cell
line due to chromosomal rearrangement [43].
Yeast Gup1p was originally recognized as a protein related to
glycerol uptake, but recently it has been identiﬁed as a protein
essential for the synthesis of the C26:0-containing GPI anchor. This
is based on the lipid analysis of GPI-APs in deletion mutants that
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acyltransferases [44]. Gup1p is an ER-localized multiple-
membrane-spanning protein harboring a motif that is characteris-
tic of membrane-bound O-acyltransferases (MBOAT). In gup1
mutant cells, the lipid moiety of most of the GPI-APs is lyso-PI.
Gup1 function is dependent on the putative active site H447 in
the MBOAT motif. Although several Gup1p homologs containing
the MBOAT motif also exist in mammals, it is unknown whether
their functions are related to GPI remodeling.
3.4. Ceramide remodeling of GPI anchor in yeast
In yeast, the lipids of many GPI-APs are transformed from the
diacylglycerol-type to the ceramide-type. This reaction seems to
occur in both the ER and the Golgi, but the species of remodeled
ceramides are different [9]. In the ER, the diacylglycerol of the
GPI lipid moiety is replaced by a ceramide consisting of PHS with
a C26 fatty acid, whereas ceramide containing PHS and a hydro-
xy-C26:0 fatty acid is used as the substrate in the Golgi. The exact
reaction involved in this type of remodeling has not been deter-
mined but it may be an exchange reaction between the diacylglyc-
erol form of GPI and a donor of ceramide by the action of either a
phospholipase C or D type enzyme.
The yeast homolog of PGAP2, CWH43, was reported to be re-
quired for cell wall integrity. In addition to the N-terminal portion
of Cwh43p, which shows approximately 24% amino acid identity
with human PGAP2, Cwh43p has an additional C-terminal portion
of approximately 700 amino acid residues. Therefore, CWH43 was
expected to have other functions in addition to PGAP2 function.
It has been reported that CWH43 is required for GPI lipid remodel-
ing to ceramides (CR in Table 1) [27,45]. In cwh43mutant cells, GPI
containing ceramide was not detected at all. Instead, accumulation
of GPI-APs bearing diacylglycerol-type GPI with a very long acyl-
chain was found. The C-terminal domain of Cwh43p is especiallyFig. 3. Biosynthesis and lipid remodeling of GPI in T. brucei. Steps 1–10, ID, FR1-FR4, and T
M1-acyl, M2-acyl, M3-acyl, A, A0 , A00 , C, C0 , Lyso-C0 , h, and h0 , respectively.important for GPI lipid remodeling to ceramides, and the N-termi-
nal domain seems to enhance the reaction [45]. The C-terminal do-
main of Cwh43p has a DNase I-like motif, which is also found in
inositol-phosphoceramide phospholipase C and phosphoinositide
phosphatases. It is possible that this motif in the C-terminal do-
main of Cwh43p is important for the recognition of inositol phos-
phate in GPI anchors. There is a homolog of the C-terminal region
of Cwh43p in mammals, but its function is still not clear, although
it was reported that the mammalian homolog of the C-terminal
region had a partial ability to restore ceramide remodeling of GPI
anchors in yeast cells [45]. There is no report about the presence
of ceramide-type GPI in mammalian cells; however, the homolog
of the C-terminal region of Cwh43p might be required for a similar
lipid remodeling in mammalian cells.
Gpi7p and Mcd4p, which transfer side-chain EtNPs to mannoses
in GPI intermediates during biosynthesis, are indirectly required
for the remodeling of diacylglycerol GPI to ceramides [9]. It might
be that ceramide remodelase is required for the recognition of
side-chain EtNP on the GPI as a substrate.
4. Peroxisome-dependent generation of alkylacyl GPI during
biosynthesis in mammals
In mammals, the lipid portion of most GPI-APs consists of 1-al-
kyl-2-acyl-PI, whereas the majority of intracellular PI species are
diacyl-types. Although the synthesis of GPI starts from diacyl-PI,
GPI intermediates are exchanged or enriched due to positive selec-
tion to 1-alkyl-2-acyl-types after acylation of inositol on GlcN-PI
(Step 4) during biosynthesis (Fig. 2) [46]. This GlcN-(acyl)PI has
an unsaturated fatty acid at the sn-2 position and consists of
alkylacyl-PI as a major type and diacyl-PI as a minor type. It is of
interest that most GPI-APs bear alkylacyl lipids in mammalian cells
yet the reaction mechanism is still unknown. It has been proposed
that peroxysomal alkyl-lipid synthesis might be required for theA correspond to those shown in Table 1. Each glycolipid is indicated as M1, M2, M3,
1676 M. Fujita, T. Kinoshita / FEBS Letters 584 (2010) 1670–1677proper function of GPI-APs from the analysis of ether lipid-deﬁ-
cient mice [47]. Very recently, it has been reported that the al-
kyl-containing lipids that are incorporated into GPI intermediates
are derived from the peroxisome-dependent alkyl-lipid synthesis
[48]. Thus, correct GPI-AP biosynthesis in mammalian cells re-
quires three organelles, the ER, Golgi and peroxisome.
5. Lipid remodeling of GPI in African trypanosomes
5.1. Inositol acylation and deacylation in the bloodstream form
In yeast and mammalian cells, once inositol of the GPI interme-
diate GlcN-PI is acylated, it is not deacylated until GPI is trans-
ferred to proteins. In the bloodstream form of T. brucei, however,
GlcN-PI is not recognized as a substrate [13]. Instead, an acyl-chain
is transferred to Man-GlcN-PI after the action of GPI-MT I (Fig. 3).
Inositol acylation in T. brucei is inhibited by phenylmethylsulfonyl
ﬂuoride and does not seem to be dependent on acyl-CoA [49]. The
gene responsible for this reaction has yet to be identiﬁed. Further-
more, it is thought that inositol acylation and deacylation is
repeated during biosynthesis, because both acylated and non-acyl-
ated GPI intermediates exist during transfer of the Man2 and Man3
to GPI intermediates. However, addition of bridging EtNP must be
carried out only to the inositol-acylated intermediate (M3-acyl)
[49]. GPIdeAc2, which is a trypanosome homolog of PGAP1, is iden-
tiﬁed as GPI inositol deacylase [50]. Knockdown of GPIdeAc2 in the
bloodstream form of T. brucei decreased the surface expression of
VSG and caused morphological abnormalities such as multiple ﬂa-
gella and multiple nuclei.
5.2. Fatty acid remodeling in bloodstream form
GPI anchors in the bloodstream form of T. brucei contain di-
myristoyl-PI exclusively and their fatty acid remodeling has been
well characterized [13]. The fatty acid remodeling in trypanosomes
occurs before GPI is transferred to proteins, whereas mammalian
and yeast lipid remodeling occurs after the attachment of GPI to
proteins. The fatty acids of GPI intermediates are replaced by
myristic acid (C14:0) through sequential deacylation and reacyla-
tion reactions at the sn-2 position followed by reactions at the
sn-1 position in the bloodstream form of T. brucei (Fig. 3). Trypan-
osomes normally derives fatty acids and phospholipids from the
host’s bloodstream, whereas the myristic acid required for remod-
eling is synthesized by the trypanosome itself [51]. Fatty acid
remodeling requires at least four steps. It has been identiﬁed that
TbGUP1, a homolog of yeast GUP1, is required for the addition of
myristic acid to the sn-2 position in this remodeling pathway
[52]. In vitro assays have demonstrated that TbGup1p prefers
shorter length fatty acids, such as C14:0 and C12:0, as a substrate.
The genes involved in the three other steps are not yet known. T.
brucei also has a secondary pathway for GPI anchor myristoylation,
named myristate exchange, which is distinct from fatty acid
remodeling [53]. Glycolipid A and GPI anchors of VSG undergo a
myristate exchange. The enzymes responsible for exchange appear
to differ from those for fatty acid remodeling. The function of myr-
istate exchange is still not clear, but it is likely to make sure that all
synthesized VSG has a myristoylated GPI or to repair VSG recycled
from the cell surface.
5.3. Structural changes of lipid and glycan on GPI in procyclic form
In the procyclic form of T. brucei, the lipid moiety of GPI is ino-
sitol-acylated lyso-PI (Fig. 3) [16]. This is because the expression of
GPIdeAc2 is strikingly decreased in the procyclic form [50]. Over-
expression of GPIdeAc2 in the procyclic form causes an accumula-tion of GPI biosynthetic intermediates lacking an inositol-linked
acyl-chain and decreased cell surface procyclins due to release into
the culture medium. Therefore, GPI inositol deacylase activity is
tightly regulated in the trypanosome life cycle for correct surface
expression of GPI-APs.
The glycan part of GPI on procyclins has a side-branch contain-
ing polylactosamine and terminal sialic acids [16]. Recently, Golgi-
localized GlcNAc transferase, involved in the addition of b1–3
linked GlcNAc to the second Gal on GPI anchor has been identiﬁed
and termed TbGT8 [54]. Sialic acids on the side-branch of GPI an-
chors are transferred from host sialo-glycoconjugates by trans-
sialidases.
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